CH Biotech R&D Co Ltd

ESG Report

Report overview

The report presents CH Biotech's 2022 sustainability performance across its Taiwan and U.S. operations, including consolidated revenue of NT$1,434,115 thousand and total GHG emissions of 3,839.712 tons of CO2e, down 3.90% from 2021. It highlights the establishment of a Corporate Sustainability Execution Team and board-level supervision of sustainability management. The report also covers water, energy, waste, workforce, human rights, occupational safety, supply-chain, and community initiatives, and includes an independent SGS assurance statement.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Assurance

Provider
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Scope 3 emissions
Energy consumption
Renewable energy
Water consumption
Waste
Employees
Women in management
Workplace fatalities
Net zero target

Materiality

Assessment
Basis
Matrix

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services